Concepedia

Jean François Ramée

JF

4

Publications

69

Citations

4

H-Index

2012

Active since

Affiliations

Hôpital Privé Jean Mermo(Current)

Hôpital Saint-Antoine

Hôpital Ambroise-Paré

Hôpital Foch

GERCOR (France)

Jean François Ramée is an author at Hôpital Privé Jean Mermo specializing in medicine, cancer therapeutics, and radiation oncology.

Top concepts

Publications per year

2012–2014

4

Publications

4

Bevacizumab (Bev) with or without erlotinib as maintenance therapy, following induction first-line chemotherapy plus Bev, in patients (pts) with metastatic colorectal cancer (mCRC): Efficacy and safety results of the International GERCOR DREAM phase III trial.

Christophe Tournigand, Benoît Samson, Werner Scheithauer et al. · Journal of Clinical Oncology · 2012 · 35 citations

, , +19

Efficacy and safety of FOLFIRINOX in patients with metastatic pancreatic cancer.

Jean Philippe Metges, Jean François Ramée, Jean‐Yves Douillard et al. · Journal of Clinical Oncology · 2014 · 13 citations

, , +22

Maintenance therapy with bevacizumab with or without erlotinib in metastatic colorectal cancer (mCRC) according to KRAS: Results of the GERCOR DREAM phase III trial.

Christophe Tournigand, Benoist Chibaudel, Benoît Samson et al. · Journal of Clinical Oncology · 2013 · 11 citations

, , +17

Bevacizumab-Erlotinib As Maintenance Therapy in Metastatic Colorectal Cancer. Final Results of the Gercor Dream Study

Benoist Chibaudel, Christophe Tournigand, Benoît Samson et al. · Annals of Oncology · 2014 · 10 citations

, , +9

Rows per page

1–4 of 4